Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 181

1.

The Papworth Bleeding Risk Score: a stratification scheme for identifying cardiac surgery patients at risk of excessive early postoperative bleeding.

Vuylsteke A, Pagel C, Gerrard C, Reddy B, Nashef S, Aldam P, Utley M.

Eur J Cardiothorac Surg. 2011 Jun;39(6):924-30. doi: 10.1016/j.ejcts.2010.10.003. Epub 2010 Nov 19.

PMID:
21094051
2.

Relationship between leukocyte count and patient risk for excessive blood loss after cardiac surgery.

Despotis GJ, Levine V, Goodnough LT.

Crit Care Med. 1997 Aug;25(8):1338-46.

PMID:
9267947
3.

Perioperative use of tirofiban hydrochloride (Aggrastat) does not increase surgical bleeding after emergency or urgent coronary artery bypass grafting.

Bizzarri F, Scolletta S, Tucci E, Lucidi M, Davoli G, Toscano T, Neri E, Muzzi L, Frati G.

J Thorac Cardiovasc Surg. 2001 Dec;122(6):1181-5.

4.

Editorial comment on The Papworth bleeding risk score: a stratification scheme for identifying cardiac surgery patients at risk of excessive early post-operative bleeding.

Jeppsson A.

Eur J Cardiothorac Surg. 2011 Jun;39(6):930-1. doi: 10.1016/j.ejcts.2010.11.022. Epub 2010 Dec 21. No abstract available.

PMID:
21177116
5.
6.

Perioperative renal outcome in cardiac surgical patients with preoperative renal dysfunction: aprotinin versus epsilon aminocaproic acid.

Maslow AD, Chaudrey A, Bert A, Schwartz C, Singh A.

J Cardiothorac Vasc Anesth. 2008 Feb;22(1):6-15. doi: 10.1053/j.jvca.2007.07.017. Epub 2007 Nov 7.

PMID:
18249324
7.

Aspirin does not increase allogeneic blood transfusion in reoperative coronary artery surgery.

Tuman KJ, McCarthy RJ, O'Connor CJ, McCarthy WE, Ivankovich AD.

Anesth Analg. 1996 Dec;83(6):1178-84.

PMID:
8942582
8.

Preoperative platelet dysfunction predicts blood product transfusion in children undergoing cardiac surgery.

Zubair MM, Bailly DK, Lantz G, Sunstrom RE, Saharan S, Boshkov LK, Sochacki P, Roger Hohimer A, Lasarev MR, Langley SM.

Interact Cardiovasc Thorac Surg. 2015 Jan;20(1):24-30. doi: 10.1093/icvts/ivu315. Epub 2014 Oct 3.

PMID:
25281704
9.

Plasma fibrinogen level, bleeding, and transfusion after on-pump coronary artery bypass grafting surgery: a prospective observational study.

Karlsson M, Ternström L, Hyllner M, Baghaei F, Nilsson S, Jeppsson A.

Transfusion. 2008 Oct;48(10):2152-8. doi: 10.1111/j.1537-2995.2008.01827.x. Epub 2008 Jul 24.

PMID:
18657083
10.

Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.

Dietrich W, Spannagl M, Boehm J, Hauner K, Braun S, Schuster T, Busley R.

Anesth Analg. 2008 Nov;107(5):1469-78. doi: 10.1213/ane.0b013e318182252b.

PMID:
18931201
11.

Atrial fibrillation after cardiac surgery: a major morbid event?

Almassi GH, Schowalter T, Nicolosi AC, Aggarwal A, Moritz TE, Henderson WG, Tarazi R, Shroyer AL, Sethi GK, Grover FL, Hammermeister KE.

Ann Surg. 1997 Oct;226(4):501-11; discussion 511-3.

12.

Risk factors for hemorrhage-related reexploration and blood transfusion after conventional versus coronary revascularization without cardiopulmonary bypass.

Frankel TL, Stamou SC, Lowery RC, Kapetanakis EI, Hill PC, Haile E, Corso PJ.

Eur J Cardiothorac Surg. 2005 Mar;27(3):494-500. Epub 2004 Dec 30.

PMID:
15740962
13.

Mid-term clinical outcomes in cardiac surgery of Jehovah's witnesses.

Pompei E, Tursi V, Guzzi G, Vendramin I, Ius F, Muzzi R, Auci E, Badano LP, Livi U.

J Cardiovasc Med (Hagerstown). 2010 Mar;11(3):170-4. doi: 10.2459/JCM.0b013e3283330752.

PMID:
19934767
14.

Prophylactic tranexamic acid in elective, primary coronary artery bypass surgery using cardiopulmonary bypass.

Andreasen JJ, Nielsen C.

Eur J Cardiothorac Surg. 2004 Aug;26(2):311-7.

PMID:
15296889
15.

Bleeding in cardiac surgery: the use of aprotinin does not affect survival.

Pagano D, Howell NJ, Freemantle N, Cunningham D, Bonser RS, Graham TR, Mascaro J, Rooney SJ, Wilson IC, Cramb R, Keogh BE.

J Thorac Cardiovasc Surg. 2008 Mar;135(3):495-502. doi: 10.1016/j.jtcvs.2007.11.045.

16.

Reexploration for bleeding after coronary artery bypass surgery: risk factors, outcomes, and the effect of time delay.

Karthik S, Grayson AD, McCarron EE, Pullan DM, Desmond MJ.

Ann Thorac Surg. 2004 Aug;78(2):527-34; discussion 534. Review.

PMID:
15276512
17.

Efficacy and safety of recombinant factor XIII on reducing blood transfusions in cardiac surgery: a randomized, placebo-controlled, multicenter clinical trial.

Karkouti K, von Heymann C, Jespersen CM, Korte W, Levy JH, Ranucci M, Sellke FW, Song HK.

J Thorac Cardiovasc Surg. 2013 Oct;146(4):927-39. doi: 10.1016/j.jtcvs.2013.04.044. Epub 2013 Jun 29.

18.

Clopidogrel does not increase bleeding and allogenic blood transfusion in coronary artery surgery.

Karabulut H, Toraman F, Evrenkaya S, Goksel O, Tarcan S, Alhan C.

Eur J Cardiothorac Surg. 2004 Mar;25(3):419-23.

PMID:
15019671
19.

Perioperative determinants of morbidity and mortality in elderly patients undergoing cardiac surgery.

Rady MY, Ryan T, Starr NJ.

Crit Care Med. 1998 Feb;26(2):225-35.

PMID:
9468158
20.

The incremental value of thrombelastography for prediction of excessive blood loss after cardiac surgery: an observational study.

Wasowicz M, McCluskey SA, Wijeysundera DN, Yau TM, Meinri M, Beattie WS, Karkouti K.

Anesth Analg. 2010 Aug;111(2):331-8. doi: 10.1213/ANE.0b013e3181e456c1. Epub 2010 Jul 7.

PMID:
20610554

Supplemental Content

Support Center